Jazz Pharmaceuticals plc
NASDAQ:JAZZ
109.56 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Jazz Pharmaceuticals plc |
Symbool | JAZZ |
Munteenheid | USD |
Prijs | 109.565 |
Beurswaarde | 6,766,022,228 |
Dividendpercentage | 0% |
52-weken bereik | 99.06 - 137.39 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Bruce C. Cozadd |
Website | https://www.jazzpharma.com |
An error occurred while fetching data.
Over Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)